Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
UBS
Boehringer Ingelheim
Queensland Health
McKesson
Covington

Generated: May 23, 2019

DrugPatentWatch Database Preview

Siltuximab - Biologic Drug Details

« Back to Dashboard

Summary for siltuximab
Tradenames:1
Patents:10
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for siltuximab
Mechanism of ActionInterleukin-6 Antagonists

US Patents for siltuximab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Try a Free Trial AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Try a Free Trial CureVac AG (Tubingen, DE) ➤ Try a Free Trial RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Try a Free Trial HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN) ➤ Try a Free Trial RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Try a Free Trial biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 001 2014-04-23 ➤ Try a Free Trial biOasis Technologies, Inc. (Richmond, CA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for siltuximab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
14C/052 Belgium ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; AUTHORISATION NUMBER AND DATE: EU/1/14/928/001 20140527
543 Luxembourg ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB
14/048 Ireland ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
2014 00047 Denmark ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140522
2014000084 Germany ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928 20140522
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Daiichi Sankyo
Citi
Medtronic
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.